ABBOTT LABORATORIES — Director's Dealing 2010

Feb 24, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2010-02-19

Reporting Person: Bohuon Olivier (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-19	Common shares without par value	A	32000	—	Acquired	97176	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-19	Option (right to buy)	$54.50	A	46900	Acquired	2020-02-18	Common shares (46900)	Direct

Footnotes

F1: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program. The units generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Each unit represents the contingent right to receive one Abbott common share.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,634 on 02/19/2011, 15,633 on 02/19/2012, and 15,633 on 02/19/2013.